This inventor holds 3 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1979-1991.
Company Filing History:
Years Active: 1979-1991
Title: Jay R Schenck: Innovator in Immunoassay Technology
Introduction
Jay R Schenck is a notable inventor based in Waukegan, IL (US). He has made significant contributions to the field of immunoassay technology, holding a total of 3 patents. His work focuses on innovative methods for detecting specific immunoglobulins and antigens in fluid samples.
Latest Patents
One of Schenck's latest patents is titled "Detection of altered IGA1 in fluid samples." This invention presents a novel immunoassay method for detecting the immunoglobulin IgA1 with O-linked oligosaccharides lacking sialic acid in fluid samples, such as blood, serum, and plasma. The method involves extracting total IgA from fluid samples through a reaction with an immobilized anti-IgA antibody, followed by the detection of only the IgA1 fraction using labeled peanut agglutinin.
Another significant patent is the "Antibody adsorbed support method for carcinoembryonic antigen assay." This invention relates to an immunoassay for carcinoembryonic antigen in plasma or sera. The process includes heat-treating the plasma or serum to obtain a supernatant, which is then incubated with a solid support that has carcinoembryonic antigen antibody adsorbed onto it. The solid support is subsequently incubated with a labeled carcinoembryonic antigen antibody, and the labeled antibody is measured and compared to standards.
Career Highlights
Jay R Schenck is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to develop and refine his innovative immunoassay techniques, contributing to advancements in medical diagnostics.
Collaborations
Throughout his career, Schenck has collaborated with notable colleagues, including Yung D Kim and Joseph T Tomita. These collaborations have further enhanced the development of his patented technologies and have contributed to the success of his projects.
Conclusion
Jay R Schenck's contributions to immunoassay technology have made a significant impact in the field of medical diagnostics. His innovative patents and collaborations reflect his dedication to advancing healthcare solutions.